HDMA joins FDA counterfeit alert network
The Healthcare Distribution Management Association has joined FDA's counterfeit alert network. As a member of the network, the wholesaler group will distribute time-sensitive FDA messages and information on specific counterfeit incidents to member companies. It will also provide educational messages about counterfeit drugs, as well as information needed to recognize and report suspect or counterfeit drug products. FDA announced the creation of the counterfeit alert network when it released its "Combating Counterfeit Drugs" report in 2004 (1"The Pink Sheet" Feb. 23, 2004, p. 17). Other members of the network include the Academy of Managed Care Pharmacy, the National Association of Chain Drug Stores and the National Community Pharmacists Association...
You may also be interested in...
An FDA counterfeit drugs 1public service announcement directs consumers to look for the "Verified Internet Pharmacy Practice Sites" seal when purchasing drugs on the internet
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.